comparemela.com

Latest Breaking News On - Boehringer ingelheim spiriva handihaler - Page 1 : comparemela.com

Lupin Q3 results: Net profit surges to Rs 613 crore

Indian drugmaker Lupin beats quarterly profit estimates on strong demand

Indian generic drugmaker Lupin reported a bigger-than-expected rise in its third-quarter profit on Wednesday, helped by strong demand in its North American and domestic markets. .

Lupin s much-awaited approval for gSpiriva is here; will it change the drug maker s fortunes?

The market has cheered the development, which comes ahead of the timeline set by Lupin s management at its March quarter earnings call, much more needs to be done before the company s fortunes turn around meaningfully.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.